Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SENSYO Pharmatech, often referred to as the Vaccine Biotechnology City, is a large-scale industrial complex located in Benslimane, Morocco, dedicated to the manufacturing of vaccines and biotechnological products. Launched as a strategic sovereign project under the leadership of King Mohammed VI, the facility aims to ensure vaccine self-sufficiency for Morocco and the African continent. The site features advanced fill-and-finish capabilities and is designed to produce a wide range of vaccines, including those for COVID-19, using various technological platforms. SENSYO operates as a public-private partnership involving the Moroccan state, leading Moroccan banks, and international technology partners like Recipharm. The facility represents a major step in establishing Morocco as a leading biotechnology hub in Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vaccine Biotechnology City.